Commentary on Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis

British Journal of Surgery

Volumn 97, Issue 2, 2010, Pages 219-

  Clements, W D B ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CHOLECYSTITIS; CHOLECYSTECTOMY; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; LENGTH OF STAY; NOTE; QUALITY ADJUSTED LIFE YEAR; TIME; TREATMENT OUTCOME;

CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLECYSTITIS, ACUTE; COST-BENEFIT ANALYSIS; HUMANS; LENGTH OF STAY; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; TREATMENT OUTCOME;

EID: 74549220360     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6959     Document Type: Note

References (29)

1. Keus F, de Jong JA, Gooszen HG, van Laarhoven CJ. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev 2006; (4)CD006231.
2. Glasgow RE, Cho M, Hutter MM, Mulvihill SJ. The spectrum and cost of complicated gallstone disease in California. Arch Surg 2000; 135: 1021–1025.
3. Gurusamy KS, Samraj K. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Cochrane Database Syst Rev 2006; (4)CD005440.
4. Gurusamy KS, Samraj K, Gluud C, Wilson E, Davidson BR. Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2009; 97: 141–150.
5. Lau H, Lo CY, Patil NG, Yuen WK. Early versus delayed-interval laparoscopic cholecystectomy for acute cholecystitis: a metaanalysis. Surg Endosc 2006; 20: 82–87.
6. Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programmes (3rd edn). Oxford University Press: Oxford, 2005.
7. Moore DE, Feurer ID, Holzman MD, Wudel LJ, Strickland C, Gorden DL et al. Long-term detrimental effect of bile duct injury on health-related quality of life. Arch Surg 2004; 139: 476–481.
8. HM Treasury. The Green Book. Appraisal and Evaluation in Central Government. http://www.hm-treasury.gov.uk/d/green_book_complete.pdf 2008; [accessed 20 July 2009].
9. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf [accessed 21 July 2009].
10. Vetrhus M, Søreide O, Nesvik I, Søndenaa K. Acute cholecystitis: delayed surgery or observation. A randomized clinical trial. Scand J Gastroenterol 2003; 38: 985 – 990.
11. Department of Health. NHS Reference Costs 2005–06. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_062884 [accessed 17 July 2007].
12. Curtis L, Netten A. Unit Costs of Health and Social Care. http://www.pssru.ac.uk/pdf/uc/uc2006/uc2006.pdf. 2006; [accessed 31 October 2008].
13. Bass EB, Pitt HA, Lillemoe KD. Cost-effectiveness of laparoscopic cholecystectomy versus open cholecystectomy. Am J Surg 1993; 165: 466–471.
14. Cook J, Richardson J. Quality of Life Measurement of Patients Receiving Treatments for Gallstone Disease: Options, Issues and Results. Working paper 33. http://www.buseco.monash.edu.au/centres/che/pubs/wp33.pdf [accessed 31 October 2008].
15. Teerawattananon Y, Mugford M. Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study. Cost Eff Resour Alloc 2005; 3: 10.
16. Arseneau KO, Cohn SM, Cominello F, Connors AF Jr. Cost–utility of initial medical management for Crohn’s disease perianal fistulae. Gastroenterology 2001; 120: 1640–1656.
17. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Apporoaches to Clinical Trials and Health-Care Evaluation. John Wiley & Sons: Chichester, 2004.
18. de Beaux AC, Palmer KR, Carter DC. Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut 1995; 37: 121–126.
19. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas 2006; 33: 323–330.
20. The Cost-Effectiveness Analysis Registry. http://www.cearegistry.org [accessed 17 April 2009].
21. Bass EB, Steinberg EP, Pitt HA, Saba GP, Lillemoe KD, Kafonek DR et al. Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones. Gastroenterology 1991; 101: 189–199.
22. Greenhalgh T. How to read a paper. Papers that tell you what things cost (economic analyses). BMJ 1997; 315: 596 – 599.
23. Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005; 14: 339–347.
24. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001; 10: 779–787.
25. Briggs A, Sculpher M, Claxton K. Decision-making, uncertainty and the value of information. In Decision Modelling for Health Economic Evaluation, Gray A, Briggs A (eds). Oxford University Press: Oxford, 2006; 165–200.
26. Senapati PS, Bhattarcharya D, Harinath G, Ammori BJ. A survey of the timing and approach to the surgical management of cholelithiasis in patients with acute biliary pancreatitis and acute cholecystitis in the UK. Ann R Coll Surg Engl 2003; 85: 306–312.
27. Dale W, Basu A, Elstein A, Meltzer D. Predicting utility ratings for joint health states from single health states in prostate cancer: empirical testing of 3 alternative theories. Med Decis Making 2008; 28: 102–112.
28. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999; 18: 341–364.
29. Raiffa H, Schlaifer R. Applied Statistical Decision Theory. Harvard Business School: Boston, 1961.